Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitro is a research paper published in Precision Nanomedicine (2021). On theSindex it has a DataRank of 0.457. It has been cited 20 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.457
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIBIB NIH HHS
Grant: R01 EB022040
NIH HHS
Grant: S10 OD010366
NIAID NIH HHS
Grant: R01 AI154959
NCI NIH HHS
Grant: R01 CA194058
National Institutes of Health
Grant: 1S10OD010366-01A1
Sensitive Triple Quadrupole Mass Spectrometer for Translational Research
National Institutes of Health
Grant: 5R01AI154959-09
The Alternative Complement Pathway and Hemocompatibility of Nanosurfaces
National Institutes of Health
Grant: 5R01CA194058-03
Painted erythrocyte carriers for therapy of acute myeloid leukemia
FWCI
1.12
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals